Source link : https://www.newshealth.biz/health-news/bariatric-surgery-demand-declines-in-the-era-of-glp-1-ras/
TOPLINE: The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for obesity treatment increased more than twofold between the last half of 2022 and the last half of 2023, whereas the rate of metabolic bariatric surgery dropped by around 25% during the same period, suggesting a notable shift in obesity management strategies. METHODOLOGY: The […]
Author : News Health
Publish date : 2024-12-05 14:00:42
Copyright for syndicated content belongs to the linked Source.